Skip to content
10-Q

Quarterly Report

Nexvet Biopharma plc

0001564590-16-027495

← back to feed
Filed
Nov 4, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Oct 31, 2016 11.73M sh
Cash And Equivalents Q1 2017 · Sep 30, 2016 $24.55M
Cash And Equivalents Q1 2017 · Jun 30, 2016 $31.48M
Cash And Equivalents Q1 2017 · Sep 30, 2015 $47.66M
Cash And Equivalents Q1 2017 · Jun 30, 2015 $52.03M
Stockholders Equity Q1 2017 · Sep 30, 2016 $30.6M
Stockholders Equity Q1 2017 · Jun 30, 2016 $35.14M
Stockholders Equity Q1 2017 · Jun 30, 2015 $53.58M
Current Liabilities Q1 2017 · Sep 30, 2016 $3.71M
Current Liabilities Q1 2017 · Jun 30, 2016 $5.05M
Total Liabilities Q1 2017 · Sep 30, 2016 $3.83M
Total Liabilities Q1 2017 · Jun 30, 2016 $5.19M
Current Assets Q1 2017 · Sep 30, 2016 $28.55M
Current Assets Q1 2017 · Jun 30, 2016 $34.96M
Total Assets Q1 2017 · Sep 30, 2016 $34.43M
Total Assets Q1 2017 · Jun 30, 2016 $40.32M
Sga Expense Q1 2017 · Sep 30, 2016 $2.23M
Sga Expense Q1 2017 · Sep 30, 2015 $1.87M
Rd Expense Q1 2017 · Sep 30, 2016 $3.47M
Rd Expense Q1 2017 · Sep 30, 2015 $3.73M
Net Income Q1 2017 · Sep 30, 2016 −$5.1M
Net Income Q1 2017 · Jun 30, 2016 −$19.37M
Net Income Q1 2017 · Sep 30, 2015 −$3.96M
Operating Income Q1 2017 · Sep 30, 2016 −$5.7M
Operating Income Q1 2017 · Sep 30, 2015 −$5.6M
Capex Q1 2017 · Sep 30, 2015 $1.89M